img

Global Influenza Medication Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Influenza Medication Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major typestype A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.
Influenza Medication report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Influenza Medication market is projected to reach US$ 742.9 million in 2034, increasing from US$ 530.3 million in 2022, with the CAGR of 4.9% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Influenza Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International
Sun Pharmaceutical Industries
Mylan
Segment by Type
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Others

Segment by Application


Hospitals
Clinics
Pharmacies
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Influenza Medication market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Influenza Medication, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Influenza Medication industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Influenza Medication in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Influenza Medication introduction, etc. Influenza Medication Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Influenza Medication market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Influenza Medication Market Overview
1.1 Influenza Medication Product Overview
1.2 Influenza Medication Market Segment by Type
1.2.1 Zanamivir
1.2.2 Oseltamivir
1.2.3 Peramivir
1.2.4 Amantadine
1.2.5 Rimantadine
1.2.6 Inosine
1.2.7 Others
1.3 Global Influenza Medication Market Size by Type
1.3.1 Global Influenza Medication Market Size Overview by Type (2024-2034)
1.3.2 Global Influenza Medication Historic Market Size Review by Type (2024-2024)
1.3.3 Global Influenza Medication Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Influenza Medication Sales Breakdown by Type (2024-2024)
1.4.2 Europe Influenza Medication Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Influenza Medication Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Influenza Medication Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Influenza Medication Sales Breakdown by Type (2024-2024)
2 Global Influenza Medication Market Competition by Company
2.1 Global Top Players by Influenza Medication Sales (2024-2024)
2.2 Global Top Players by Influenza Medication Revenue (2024-2024)
2.3 Global Top Players by Influenza Medication Price (2024-2024)
2.4 Global Top Manufacturers Influenza Medication Manufacturing Base Distribution, Sales Area, Product Type
2.5 Influenza Medication Market Competitive Situation and Trends
2.5.1 Influenza Medication Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Influenza Medication Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Medication as of 2022)
2.7 Date of Key Manufacturers Enter into Influenza Medication Market
2.8 Key Manufacturers Influenza Medication Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Influenza Medication Status and Outlook by Region
3.1 Global Influenza Medication Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Influenza Medication Historic Market Size by Region
3.2.1 Global Influenza Medication Sales in Volume by Region (2024-2024)
3.2.2 Global Influenza Medication Sales in Value by Region (2024-2024)
3.2.3 Global Influenza Medication Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Influenza Medication Forecasted Market Size by Region
3.3.1 Global Influenza Medication Sales in Volume by Region (2024-2034)
3.3.2 Global Influenza Medication Sales in Value by Region (2024-2034)
3.3.3 Global Influenza Medication Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Influenza Medication by Application
4.1 Influenza Medication Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Pharmacies
4.1.4 Others
4.2 Global Influenza Medication Market Size by Application
4.2.1 Global Influenza Medication Market Size Overview by Application (2024-2034)
4.2.2 Global Influenza Medication Historic Market Size Review by Application (2024-2024)
4.2.3 Global Influenza Medication Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Influenza Medication Sales Breakdown by Application (2024-2024)
4.3.2 Europe Influenza Medication Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Influenza Medication Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Influenza Medication Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Influenza Medication Sales Breakdown by Application (2024-2024)
5 North America Influenza Medication by Country
5.1 North America Influenza Medication Historic Market Size by Country
5.1.1 North America Influenza Medication Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Influenza Medication Sales in Volume by Country (2024-2024)
5.1.3 North America Influenza Medication Sales in Value by Country (2024-2024)
5.2 North America Influenza Medication Forecasted Market Size by Country
5.2.1 North America Influenza Medication Sales in Volume by Country (2024-2034)
5.2.2 North America Influenza Medication Sales in Value by Country (2024-2034)
6 Europe Influenza Medication by Country
6.1 Europe Influenza Medication Historic Market Size by Country
6.1.1 Europe Influenza Medication Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Influenza Medication Sales in Volume by Country (2024-2024)
6.1.3 Europe Influenza Medication Sales in Value by Country (2024-2024)
6.2 Europe Influenza Medication Forecasted Market Size by Country
6.2.1 Europe Influenza Medication Sales in Volume by Country (2024-2034)
6.2.2 Europe Influenza Medication Sales in Value by Country (2024-2034)
7 Asia-Pacific Influenza Medication by Region
7.1 Asia-Pacific Influenza Medication Historic Market Size by Region
7.1.1 Asia-Pacific Influenza Medication Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Influenza Medication Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Influenza Medication Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Influenza Medication Forecasted Market Size by Region
7.2.1 Asia-Pacific Influenza Medication Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Influenza Medication Sales in Value by Region (2024-2034)
8 Latin America Influenza Medication by Country
8.1 Latin America Influenza Medication Historic Market Size by Country
8.1.1 Latin America Influenza Medication Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Influenza Medication Sales in Volume by Country (2024-2024)
8.1.3 Latin America Influenza Medication Sales in Value by Country (2024-2024)
8.2 Latin America Influenza Medication Forecasted Market Size by Country
8.2.1 Latin America Influenza Medication Sales in Volume by Country (2024-2034)
8.2.2 Latin America Influenza Medication Sales in Value by Country (2024-2034)
9 Middle East and Africa Influenza Medication by Country
9.1 Middle East and Africa Influenza Medication Historic Market Size by Country
9.1.1 Middle East and Africa Influenza Medication Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Influenza Medication Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Influenza Medication Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Influenza Medication Forecasted Market Size by Country
9.2.1 Middle East and Africa Influenza Medication Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Influenza Medication Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Daiichi Sankyo Company
10.1.1 Daiichi Sankyo Company Company Information
10.1.2 Daiichi Sankyo Company Introduction and Business Overview
10.1.3 Daiichi Sankyo Company Influenza Medication Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Daiichi Sankyo Company Influenza Medication Products Offered
10.1.5 Daiichi Sankyo Company Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Information
10.2.2 GlaxoSmithKline Introduction and Business Overview
10.2.3 GlaxoSmithKline Influenza Medication Sales, Revenue and Gross Margin (2024-2024)
10.2.4 GlaxoSmithKline Influenza Medication Products Offered
10.2.5 GlaxoSmithKline Recent Development
10.3 Natco Pharma
10.3.1 Natco Pharma Company Information
10.3.2 Natco Pharma Introduction and Business Overview
10.3.3 Natco Pharma Influenza Medication Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Natco Pharma Influenza Medication Products Offered
10.3.5 Natco Pharma Recent Development
10.4 F. Hoffmann-La Roche
10.4.1 F. Hoffmann-La Roche Company Information
10.4.2 F. Hoffmann-La Roche Introduction and Business Overview
10.4.3 F. Hoffmann-La Roche Influenza Medication Sales, Revenue and Gross Margin (2024-2024)
10.4.4 F. Hoffmann-La Roche Influenza Medication Products Offered
10.4.5 F. Hoffmann-La Roche Recent Development
10.5 Teva Pharmaceutical
10.5.1 Teva Pharmaceutical Company Information
10.5.2 Teva Pharmaceutical Introduction and Business Overview
10.5.3 Teva Pharmaceutical Influenza Medication Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Teva Pharmaceutical Influenza Medication Products Offered
10.5.5 Teva Pharmaceutical Recent Development
10.6 Sandoz International
10.6.1 Sandoz International Company Information
10.6.2 Sandoz International Introduction and Business Overview
10.6.3 Sandoz International Influenza Medication Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Sandoz International Influenza Medication Products Offered
10.6.5 Sandoz International Recent Development
10.7 Sun Pharmaceutical Industries
10.7.1 Sun Pharmaceutical Industries Company Information
10.7.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.7.3 Sun Pharmaceutical Industries Influenza Medication Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Sun Pharmaceutical Industries Influenza Medication Products Offered
10.7.5 Sun Pharmaceutical Industries Recent Development
10.8 Mylan
10.8.1 Mylan Company Information
10.8.2 Mylan Introduction and Business Overview
10.8.3 Mylan Influenza Medication Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Mylan Influenza Medication Products Offered
10.8.5 Mylan Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Influenza Medication Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Influenza Medication Industrial Chain Analysis
11.4 Influenza Medication Market Dynamics
11.4.1 Influenza Medication Industry Trends
11.4.2 Influenza Medication Market Drivers
11.4.3 Influenza Medication Market Challenges
11.4.4 Influenza Medication Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Influenza Medication Distributors
12.3 Influenza Medication Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Zanamivir
Table 2. Major Company of Oseltamivir
Table 3. Major Company of Peramivir
Table 4. Major Company of Amantadine
Table 5. Major Company of Rimantadine
Table 6. Major Company of Inosine
Table 7. Major Company of Others
Table 8. Global Influenza Medication Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 9. Global Influenza Medication Sales by Type (2024-2024) & (K Units)
Table 10. Global Influenza Medication Sales Market Share in Volume by Type (2024-2024)
Table 11. Global Influenza Medication Sales by Type (2024-2024) & (US& Million)
Table 12. Global Influenza Medication Market Share in Value by Type (2024-2024)
Table 13. Global Influenza Medication Price by Type (2024-2024) & (USD/Unit)
Table 14. Global Influenza Medication Sales by Type (2024-2034) & (K Units)
Table 15. Global Influenza Medication Sales Market Share in Volume by Type (2024-2034)
Table 16. Global Influenza Medication Sales by Type (2024-2034) & (US$ Million)
Table 17. Global Influenza Medication Sales Market Share in Value by Type (2024-2034)
Table 18. Global Influenza Medication Price by Type (2024-2034) & (USD/Unit)
Table 19. North America Influenza Medication Sales by Type (2024-2024) & (K Units)
Table 20. North America Influenza Medication Sales by Type (2024-2024) & (US$ Million)
Table 21. Europe Influenza Medication Sales (K Units) by Type (2024-2024)
Table 22. Europe Influenza Medication Sales by Type (2024-2024) & (US$ Million)
Table 23. Asia-Pacific Influenza Medication Sales (K Units) by Type (2024-2024)
Table 24. Asia-Pacific Influenza Medication Sales by Type (2024-2024) & (US$ Million)
Table 25. Latin America Influenza Medication Sales (K Units) by Type (2024-2024)
Table 26. Latin America Influenza Medication Sales by Type (2024-2024) & (US$ Million)
Table 27. Middle East and Africa Influenza Medication Sales (K Units) by Type (2024-2024)
Table 28. Middle East and Africa Influenza Medication Sales by Type (2024-2024) & (US$ Million)
Table 29. Global Influenza Medication Sales by Company (2024-2024) & (K Units)
Table 30. Global Influenza Medication Sales Share by Company (2024-2024)
Table 31. Global Influenza Medication Revenue by Company (2024-2024) & (US$ Million)
Table 32. Global Influenza Medication Revenue Share by Company (2024-2024)
Table 33. Global Market Influenza Medication Price by Company (2024-2024) & (USD/Unit)
Table 34. Global Influenza Medication Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global Influenza Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Medication as of 2022)
Table 37. Date of Key Manufacturers Enter into Influenza Medication Market
Table 38. Key Manufacturers Influenza Medication Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global Influenza Medication Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 41. Global Influenza Medication Sales by Region (2024-2024) & (K Units)
Table 42. Global Influenza Medication Sales Market Share in Volume by Region (2024-2024)
Table 43. Global Influenza Medication Sales by Region (2024-2024) & (US$ Million)
Table 44. Global Influenza Medication Sales Market Share in Value by Region (2024-2024)
Table 45. Global Influenza Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 46. Global Influenza Medication Sales by Region (2024-2034) & (K Units)
Table 47. Global Influenza Medication Sales Market Share in Volume by Region (2024-2034)
Table 48. Global Influenza Medication Sales by Region (2024-2034) & (US$ Million)
Table 49. Global Influenza Medication Sales Market Share in Value by Region (2024-2034)
Table 50. Global Influenza Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 51. Global Influenza Medication Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 52. Global Influenza Medication Sales by Application (2024-2024) & (K Units)
Table 53. Global Influenza Medication Sales Market Share in Volume by Application (2024-2024)
Table 54. Global Influenza Medication Sales by Application (2024-2024) & (US$ Million)
Table 55. Global Influenza Medication Sales Market Share in Value by Application (2024-2024)
Table 56. Global Influenza Medication Price by Application (2024-2024) & (USD/Unit)
Table 57. Global Influenza Medication Sales by Application (2024-2034) & (K Units)
Table 58. Global Influenza Medication Sales Market Share in Volume by Application (2024-2034)
Table 59. Global Influenza Medication Sales by Application (2024-2034) & (US$ Million)
Table 60. Global Influenza Medication Sales Market Share in Value by Application (2024-2034)
Table 61. Global Influenza Medication Price by Application (2024-2034) & (USD/Unit)
Table 62. North America Influenza Medication Sales by Application (2024-2024) (K Units)
Table 63. North America Influenza Medication Sales by Application (2024-2024) & (US$ Million)
Table 64. Europe Influenza Medication Sales by Application (2024-2024) (K Units)
Table 65. Europe Influenza Medication Sales by Application (2024-2024) & (US$ Million)
Table 66. Asia-Pacific Influenza Medication Sales by Application (2024-2024) (K Units)
Table 67. Asia-Pacific Influenza Medication Sales by Application (2024-2024) & (US$ Million)
Table 68. Latin America Influenza Medication Sales by Application (2024-2024) (K Units)
Table 69. Latin America Influenza Medication Sales by Application (2024-2024) & (US$ Million)
Table 70. Middle East and Africa Influenza Medication Sales by Application (2024-2024) (K Units)
Table 71. Middle East and Africa Influenza Medication Sales by Application (2024-2024) & (US$ Million)
Table 72. North America Influenza Medication Sales by Country (2024-2024) & (K Units)
Table 73. North America Influenza Medication Sales Market Share in Volume by Country (2024-2024)
Table 74. North America Influenza Medication Sales by Country (2024-2024) & (US$ Million)
Table 75. North America Influenza Medication Sales Market Share in Value by Country (2024-2024)
Table 76. North America Influenza Medication Sales by Country (2024-2034) & (K Units)
Table 77. North America Influenza Medication Sales Market Share in Volume by Country (2024-2034)
Table 78. North America Influenza Medication Sales by Country (2024-2034) & (US$ Million)
Table 79. North America Influenza Medication Sales Market Share in Value by Country (2024-2034)
Table 80. Europe Influenza Medication Sales by Country (2024-2024) & (K Units)
Table 81. Europe Influenza Medication Sales Market Share in Volume by Country (2024-2024)
Table 82. Europe Influenza Medication Sales by Country (2024-2024) & (US$ Million)
Table 83. Europe Influenza Medication Sales Market Share in Value by Country (2024-2024)
Table 84. Europe Influenza Medication Sales by Country (2024-2034) & (K Units)
Table 85. Europe Influenza Medication Sales Market Share in Volume by Country (2024-2034)
Table 86. Europe Influenza Medication Sales by Country (2024-2034) & (US$ Million)
Table 87. Europe Influenza Medication Sales Market Share in Value by Country (2024-2034)
Table 88. Asia-Pacific Influenza Medication Sales by Region (2024-2024) & (K Units)
Table 89. Asia-Pacific Influenza Medication Sales Market Share in Volume by Region (2024-2024)
Table 90. Asia-Pacific Influenza Medication Sales by Region (2024-2024) & (US$ Million)
Table 91. Asia-Pacific Influenza Medication Sales Market Share in Value by Region (2024-2024)
Table 92. Asia-Pacific Influenza Medication Sales by Region (2024-2034) & (K Units)
Table 93. Asia-Pacific Influenza Medication Sales Market Share in Volume by Region (2024-2034)
Table 94. Asia-Pacific Influenza Medication Sales by Region (2024-2034) & (US$ Million)
Table 95. Asia-Pacific Influenza Medication Sales Market Share in Value by Region (2024-2034)
Table 96. Latin America Influenza Medication Sales by Country (2024-2024) & (K Units)
Table 97. Latin America Influenza Medication Sales Market Share in Volume by Country (2024-2024)
Table 98. Latin America Influenza Medication Sales by Country (2024-2024) & (US$ Million)
Table 99. Latin America Influenza Medication Sales Market Share in Value by Country (2024-2024)
Table 100. Latin America Influenza Medication Sales by Country (2024-2034) & (K Units)
Table 101. Latin America Influenza Medication Sales Market Share in Volume by Country (2024-2034)
Table 102. Latin America Influenza Medication Sales by Country (2024-2034) & (US$ Million)
Table 103. Latin America Influenza Medication Sales Market Share in Value by Country (2024-2034)
Table 104. Middle East and Africa Influenza Medication Sales by Country (2024-2024) & (K Units)
Table 105. Middle East and Africa Influenza Medication Sales Market Share in Volume by Country (2024-2024)
Table 106. Middle East and Africa Influenza Medication Sales by Country (2024-2024) & (US$ Million)
Table 107. Middle East and Africa Influenza Medication Sales Market Share in Value by Country (2024-2024)
Table 108. Middle East and Africa Influenza Medication Sales by Country (2024-2034) & (K Units)
Table 109. Middle East and Africa Influenza Medication Sales Market Share in Volume by Country (2024-2034)
Table 110. Middle East and Africa Influenza Medication Sales by Country (2024-2034) & (US$ Million)
Table 111. Middle East and Africa Influenza Medication Sales Market Share in Value by Country (2024-2034)
Table 112. Daiichi Sankyo Company Company Information
Table 113. Daiichi Sankyo Company Introduction and Business Overview
Table 114. Daiichi Sankyo Company Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 115. Daiichi Sankyo Company Influenza Medication Product
Table 116. Daiichi Sankyo Company Recent Development
Table 117. GlaxoSmithKline Company Information
Table 118. GlaxoSmithKline Introduction and Business Overview
Table 119. GlaxoSmithKline Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 120. GlaxoSmithKline Influenza Medication Product
Table 121. GlaxoSmithKline Recent Development
Table 122. Natco Pharma Company Information
Table 123. Natco Pharma Introduction and Business Overview
Table 124. Natco Pharma Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 125. Natco Pharma Influenza Medication Product
Table 126. Natco Pharma Recent Development
Table 127. F. Hoffmann-La Roche Company Information
Table 128. F. Hoffmann-La Roche Introduction and Business Overview
Table 129. F. Hoffmann-La Roche Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 130. F. Hoffmann-La Roche Influenza Medication Product
Table 131. F. Hoffmann-La Roche Recent Development
Table 132. Teva Pharmaceutical Company Information
Table 133. Teva Pharmaceutical Introduction and Business Overview
Table 134. Teva Pharmaceutical Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 135. Teva Pharmaceutical Influenza Medication Product
Table 136. Teva Pharmaceutical Recent Development
Table 137. Sandoz International Company Information
Table 138. Sandoz International Introduction and Business Overview
Table 139. Sandoz International Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 140. Sandoz International Influenza Medication Product
Table 141. Sandoz International Recent Development
Table 142. Sun Pharmaceutical Industries Company Information
Table 143. Sun Pharmaceutical Industries Introduction and Business Overview
Table 144. Sun Pharmaceutical Industries Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 145. Sun Pharmaceutical Industries Influenza Medication Product
Table 146. Sun Pharmaceutical Industries Recent Development
Table 147. Mylan Company Information
Table 148. Mylan Introduction and Business Overview
Table 149. Mylan Influenza Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 150. Mylan Influenza Medication Product
Table 151. Mylan Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Influenza Medication Market Trends
Table 155. Influenza Medication Market Drivers
Table 156. Influenza Medication Market Challenges
Table 157. Influenza Medication Market Restraints
Table 158. Influenza Medication Distributors List
Table 159. Influenza Medication Downstream Customers
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Medication Product Picture
Figure 2. Global Influenza Medication Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Influenza Medication Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Influenza Medication Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Zanamivir
Figure 6. Global Zanamivir Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Oseltamivir
Figure 8. Global Oseltamivir Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Peramivir
Figure 10. Global Peramivir Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Amantadine
Figure 12. Global Amantadine Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Rimantadine
Figure 14. Global Rimantadine Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Product Picture of Inosine
Figure 16. Global Inosine Sales YoY Growth (2024-2034) & (K Units)
Figure 17. Product Picture of Others
Figure 18. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 19. Global Influenza Medication Sales by Type (2024-2034) & (US$ Million)
Figure 20. Global Influenza Medication Sales Market Share by Type in 2022 & 2034
Figure 21. North America Influenza Medication Sales Market Share in Volume by Type in 2022
Figure 22. North America Influenza Medication Sales Market Share in Value by Type in 2022
Figure 23. Europe Influenza Medication Sales Market Share in Volume by Type in 2022
Figure 24. Europe Influenza Medication Sales Market Share in Value by Type in 2022
Figure 25. Asia-Pacific Influenza Medication Sales Market Share in Volume by Type in 2022
Figure 26. Asia-Pacific Influenza Medication Sales Market Share in Value by Type in 2022
Figure 27. Latin America Influenza Medication Sales Market Share in Volume by Type in 2022
Figure 28. Latin America Influenza Medication Sales Market Share in Value by Type in 2022
Figure 29. Middle East and Africa Influenza Medication Sales Market Share in Volume by Type in 2022
Figure 30. Middle East and Africa Influenza Medication Sales Market Share in Value by Type in 2022
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Medication Sales in 2022
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Medication Revenue in 2022
Figure 33. Influenza Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 34. Product Picture of Hospitals
Figure 35. Global Hospitals Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of Clinics
Figure 37. Global Clinics Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Product Picture of Pharmacies
Figure 39. Global Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 40. Product Picture of Others
Figure 41. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 42. Global Influenza Medication Sales by Application (2024-2034) & (US$ Million)
Figure 43. Global Influenza Medication Sales Market Share by Application in 2022 & 2034
Figure 44. North America Influenza Medication Sales Market Share in Volume by Application in 2022
Figure 45. North America Influenza Medication Sales Market Share in Value by Application in 2022
Figure 46. Europe Influenza Medication Sales Market Share in Volume by Application in 2022
Figure 47. Europe Influenza Medication Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Influenza Medication Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Influenza Medication Sales Market Share in Value by Application in 2022
Figure 50. Latin America Influenza Medication Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Influenza Medication Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Influenza Medication Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Influenza Medication Manufacturing Cost Structure
Figure 55. Influenza Medication Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries